Literature DB >> 15917101

Prion protein (PrPc) promotes beta-amyloid plaque formation.

Katja Schwarze-Eicker1, Kathy Keyvani, Nicole Görtz, David Westaway, Norbert Sachser, Werner Paulus.   

Abstract

Prion protein (PrP) has been localized to amyloid-beta (Abeta) senile plaques in aging and Alzheimer disease, but it is unknown whether PrP is directly involved in plaque formation or represents a reaction to amyloid deposition. To evaluate possible functional effects of PrP in Abeta plaque formation, we analyzed bigenic mice (TgCRND8/Tg7), carrying mutant human amyloid precursor protein (APP) 695 (APP(Swed+Ind), TgCRND8) as well as the wild-type Syrian hamster prion protein gene (sHaPrP, Tg7), showing Abeta plaques at 3 months of age as well as highly increased HaPrP(c) levels. Compared to the control group, consisting of animals carrying only mutant APP, bigenic mice showed a higher number of senile plaques in the cerebral cortex, while APP transcription and Abeta40/Abeta42 levels were unchanged. Double-labelling immunofluorescence showed co-localization of Abeta and PrP in virtually all plaques in the brains of both control and experimental animals. Our data suggest that PrP promotes plaque formation, and that this hitherto unknown functional role of PrP appears to be mediated by increased Abeta aggregation rather than by altered APP transcription or processing.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15917101     DOI: 10.1016/j.neurobiolaging.2004.10.004

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  29 in total

1.  Memory impairment in transgenic Alzheimer mice requires cellular prion protein.

Authors:  David A Gimbel; Haakon B Nygaard; Erin E Coffey; Erik C Gunther; Juha Laurén; Zachary A Gimbel; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

2.  Prion protein gene M129 allele is a risk factor for Alzheimer's disease.

Authors:  M Gacia; K Safranow; M Styczyńska; K Jakubowska; B Pepłońska; M Chodakowska-Zebrowska; I Przekop; A Słowik; E Golańska; K Hułas-Bigoszewska; D Chlubek; D Religa; C Zekanowski; M Barcikowska
Journal:  J Neural Transm (Vienna)       Date:  2006-08-08       Impact factor: 3.575

3.  Regulation of amyloid-β production by the prion protein.

Authors:  Heledd H Griffiths; Isobel J Whitehouse; Nigel M Hooper
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

4.  Prion protein interacts with BACE1 protein and differentially regulates its activity toward wild type and Swedish mutant amyloid precursor protein.

Authors:  Heledd H Griffiths; Isobel J Whitehouse; Herbert Baybutt; Debbie Brown; Katherine A B Kellett; Carolyn D Jackson; Anthony J Turner; Pedro Piccardo; Jean C Manson; Nigel M Hooper
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

5.  Different CSF β-amyloid processing in Alzheimer's and Creutzfeldt-Jakob disease.

Authors:  Brit Mollenhauer; Hermann Esselmann; Sigrun Roeber; Walter J Schulz-Schaeffer; Claudia Trenkwalder; Mirko Bibl; Petra Steinacker; Hans A Kretzschmar; Jens Wiltfang; Markus Otto
Journal:  J Neural Transm (Vienna)       Date:  2011-01-06       Impact factor: 3.575

6.  Context dependent neuroprotective properties of prion protein (PrP).

Authors:  Andrew D Steele; Zhipeng Zhou; Walker S Jackson; Chunni Zhu; Pavan Auluck; Michael A Moskowitz; Marie-Francoise Chesselet; Susan Lindquist
Journal:  Prion       Date:  2009-10-16       Impact factor: 3.931

Review 7.  Cellular prion protein mediates the toxicity of beta-amyloid oligomers: implications for Alzheimer disease.

Authors:  Haakon B Nygaard; Stephen M Strittmatter
Journal:  Arch Neurol       Date:  2009-11

Review 8.  Prion protein and Alzheimer disease.

Authors:  Katherine A B Kellett; Nigel M Hooper
Journal:  Prion       Date:  2009-10-02       Impact factor: 3.931

9.  Role of PrP(C) Expression in Tau Protein Levels and Phosphorylation in Alzheimer's Disease Evolution.

Authors:  C Vergara; L Ordóñez-Gutiérrez; F Wandosell; I Ferrer; J A del Río; R Gavín
Journal:  Mol Neurobiol       Date:  2014-06-26       Impact factor: 5.590

Review 10.  Cross currents in protein misfolding disorders: interactions and therapy.

Authors:  Rodrigo Morales; Kristi M Green; Claudio Soto
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-11       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.